Literature DB >> 22400808

Advancement in multifunctional nanoparticles for the effective treatment of cancer.

Mahfoozur Rahman1, Mohammad Zaki Ahmad, Imran Kazmi, Sohail Akhter, Muhammad Afzal, Gaurav Gupta, Farhan Jalees Ahmed, Firoz Anwar.   

Abstract

INTRODUCTION: Nanotechnology has gained wider importance for the treatment of various diseases, including cancer. Multifunctional or theranostic agents are emerging as promising therapeutic paradigms, which provide attractive vehicles for both image and therapeutic agents. Nanosystems are capable of diagnosis, specific targeted drug therapy and monitoring therapeutic response. Due to their well-developed surface nature, nanomolecules are easy to anchor with multifunctional groups. AREAS COVERED: The present review aims to give an extensive account on the progress of multifunctional nanoparticles throughout the blooming research with regards to their clinical application in cancer. This paper discusses graphene, a newly developed multifunctional vehicle in nanotechnology. Furthermore, it focuses on the development of tumor cells, the advantages of novel multifunctional nanoparticles over traditional methods and the use of nanoparticles in cancer therapy. In addition, patents issued by the US office are also included. EXPERT OPINION: Despite numerous advantages, multifunctional nanoparticles are still at an infancy stage. Many great achievements have been attained in this field to date, but many challenges still remain. A problem that limits the use of multifunctional nanoparticles is toxicity. If this toxicity can be overcome then the advancement in nanocomposite material science will be well on the way to a prospective treatment of cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22400808     DOI: 10.1517/17425247.2012.668522

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  7 in total

1.  Design and testing of paramagnetic liposome-based CEST agents for MRI visualization of payload release on pH-induced and ultrasound stimulation.

Authors:  Daniela Delli Castelli; Cinzia Boffa; Pierangela Giustetto; Enzo Terreno; Silvio Aime
Journal:  J Biol Inorg Chem       Date:  2013-09-14       Impact factor: 3.358

2.  Nanoparticle Targeting of Neutrophils for Improved Cancer Immunotherapy.

Authors:  Dafeng Chu; Qi Zhao; Jian Yu; Faya Zhang; Hui Zhang; Zhenjia Wang
Journal:  Adv Healthc Mater       Date:  2016-03-17       Impact factor: 9.933

3.  Strategy for chemotherapeutic delivery using a nanosized porous metal-organic framework with a central composite design.

Authors:  Yingpeng Li; Xiuyan Li; Qingxia Guan; Chunjing Zhang; Ting Xu; Yujing Dong; Xinyu Bai; Weiping Zhang
Journal:  Int J Nanomedicine       Date:  2017-02-22

Review 4.  Somatostatin receptors as a new active targeting sites for nanoparticles.

Authors:  Ahmed A H Abdellatif; Sa'ed M Aldalaen; Waleed Faisal; Hesham M Tawfeek
Journal:  Saudi Pharm J       Date:  2018-05-31       Impact factor: 4.330

Review 5.  Delivery of Natural Agents by Means of Mesoporous Silica Nanospheres as a Promising Anticancer Strategy.

Authors:  Khaled AbouAitah; Witold Lojkowski
Journal:  Pharmaceutics       Date:  2021-01-22       Impact factor: 6.321

Review 6.  Investigating the role of peptides in effective therapies against cancer.

Authors:  Reza Naeimi; Asrin Bahmani; Saeid Afshar
Journal:  Cancer Cell Int       Date:  2022-03-27       Impact factor: 5.722

7.  Anti-cancer peptide-based therapeutic strategies in solid tumors.

Authors:  Mohsen Karami Fath; Kimiya Babakhaniyan; Maryam Zokaei; Azadeh Yaghoubian; Sadaf Akbari; Mahdieh Khorsandi; Asma Soofi; Mohsen Nabi-Afjadi; Hamidreza Zalpoor; Fateme Jalalifar; Ali Azargoonjahromi; Zahra Payandeh; Armina Alagheband Bahrami
Journal:  Cell Mol Biol Lett       Date:  2022-04-09       Impact factor: 8.702

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.